LIVE

Serial Number

87817911

Owner

KNACK PHARMACEUTICALS, INC.

Attorney

Tomas Maria Casalins

First Use Date

Aug 1, 2021

Filing Date

Mar 2, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

K Trademark

Serial Number: 87817911 • Registration: 6540124

K is a trademark filed by KNACK PHARMACEUTICALS, INC. on March 2, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

KNACK PHARMACEUTICALS, INC. (12 trademarks)

New York City, NY 10022

Entity Type: 03

Legal Representation

Attorney of Record

Tomas Maria Casalins

8 trademarks filed View all →

Correspondence Address

Tomas Maria Casalins Fox Horan & Camerini LLP

885 Third Avenue

New York

NY 10022

UNITED STATES

Trademark Details

Filing Date

March 2, 2018

Registration Date

October 26, 2021

First Use Anywhere

August 1, 2021

First Use in Commerce

August 1, 2021

Published for Opposition

July 17, 2018

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 21, 2023 TCCA

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Sep 21, 2023 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Sep 21, 2023 COAR

COUNTERCLAIM OPP. NO. 999999

Jul 11, 2023 CCON

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 17, 2021 TCCA

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Nov 17, 2021 EWAF

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 17, 2021 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 17, 2021 REAP

REGISTERED-PRINCIPAL REGISTER

Oct 26, 2021 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 18, 2021 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 17, 2021 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Sep 17, 2021 SUPC

USE AMENDMENT FILED

Sep 10, 2021 IUAF

TEAS STATEMENT OF USE RECEIVED

Sep 10, 2021 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 17, 2021 EXRA

SOU EXTENSION 5 GRANTED

Mar 16, 2021 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 16, 2021 AITU

SOU EXTENSION 5 FILED

Mar 2, 2021 EXT5

SOU TEAS EXTENSION RECEIVED

Mar 2, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 8, 2020 EXRA

SOU EXTENSION 4 GRANTED

Aug 6, 2020 EX4G

SOU EXTENSION 4 FILED

Aug 6, 2020 EXT4

SOU TEAS EXTENSION RECEIVED

Aug 6, 2020 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 7, 2020 EXRA

SOU EXTENSION 3 GRANTED

Mar 5, 2020 EX3G

SOU EXTENSION 3 FILED

Mar 5, 2020 EXT3

SOU TEAS EXTENSION RECEIVED

Mar 5, 2020 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 30, 2019 EXRA

SOU EXTENSION 2 GRANTED

Aug 28, 2019 EX2G

SOU EXTENSION 2 FILED

Aug 28, 2019 EXT2

SOU TEAS EXTENSION RECEIVED

Aug 28, 2019 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 6, 2019 EXRA

SOU EXTENSION 1 GRANTED

Mar 4, 2019 EX1G

SOU EXTENSION 1 FILED

Mar 4, 2019 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 4, 2019 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 11, 2018 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 17, 2018 NPUB

PUBLISHED FOR OPPOSITION

Jul 17, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 27, 2018 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 13, 2018 CNSA

ASSIGNED TO EXAMINER

Jun 13, 2018 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Mar 10, 2018 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 9, 2018 NWOS

NEW APPLICATION ENTERED

Mar 6, 2018 NWAP

Related Trademarks

More from this Owner

K KNACK PHARMACEUTICALS YOUR HEALTH PARTNER

K KNACK PHARMACEUTICALS

KNACK PHARMACEUTICALS YOUR HEALTH PARTNER

K KNACK PHARMACEUTICALS YOUR HEALTH PARTNER

K KNACK PHARMACEUTICALS

More in Same Class

NATURGIN PRODUCTS USA

TEAR FLO